Fidelity Investments’s Enfusion, Inc. ENFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,860
Closed -$20.7K 5550
2025
Q1
$20.7K Buy
1,860
+1,326
+248% +$14.7K ﹤0.01% 4212
2024
Q4
$5.5K Sell
534
-106
-17% -$1.02K ﹤0.01% 4647
2024
Q3
$6.07K Sell
640
-107
-14% -$923 ﹤0.01% 4575
2024
Q2
$6.36K Sell
747
-157
-17% -$1.44K ﹤0.01% 4479
2024
Q1
$8.36K Buy
904
+110
+14% +$968 ﹤0.01% 4340
2023
Q4
$7.7K Buy
794
+205
+35% +$1.92K ﹤0.01% 4318
2023
Q3
$5.28K Buy
589
+413
+235% +$3.92K ﹤0.01% 4321
2023
Q2
$1.98K Sell
176
-212
-55% -$1.88K ﹤0.01% 4595
2023
Q1
$4.07K Buy
388
+146
+60% +$1.61K ﹤0.01% 4442
2022
Q4
$2.34K Sell
242
-384
-61% -$4.32K ﹤0.01% 4468
2022
Q3
$8K Buy
626
+387
+162% +$4.72K ﹤0.01% 4174
2022
Q2
$2K Buy
239
+202
+546% +$2.23K ﹤0.01% 4622
2022
Q1
$0 Buy
+37
New +$565 ﹤0.01% 5583

Other funds holding ENFN

Fidelity Investments's ENFN Position: Q2 2025 in Review

Fidelity Investments sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 1,860 shares — an estimated $20.7K sold.

Fidelity Investments first reported a position in ENFN in Q1 2022 and held it in 13 quarters. The position peaked at $20.7K in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • Fidelity Investments reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • Fidelity Investments sold 1,860 Enfusion, Inc. shares in Q2 2025, an estimated $20.7K.
  • Fidelity Investments first reported a position in Enfusion, Inc. in Q1 2022 and held it in 13 quarters.
  • Fidelity Investments's Enfusion, Inc. position peaked at $20.7K in Q1 2025.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Fidelity Investments's 13F filing for Q2 2025, filed 14 Aug 2025.